BIO
Bio-Rad Laboratories, Inc.
Healthcare · Medical Devices · NYQ
$305.29
Close 2026-05-28
✓ ETHICAL PASS

UNKNOWN MOAT
HIGH
Data Confidence: 100%
Full financial profile available
Market Cap
$8.2B
Trailing P/E
50.80
Forward P/E
31.40
Rev Growth
+1.1%
Profit Margin
6.5%
ROE
2.5%
Analyst Target
$300.00
Recommendation
HOLD
About Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Ethical Screen
Business ActivityPASS
Debt RatioN/A
Cash RatioN/A
Receivables RatioN/A
Revenue Ratio (0.00%)PASS
OverallPASS
Score Ethical: 64.7
Score Valuation: 36.5
Score Quality: 45.2
Score Combined: 43.9

Full Analysis

Opportunity scores, earnings history, insider transactions, institutional holders, analyst consensus, and more.

Unlock with Membership
Opportunity Scores
Valuation38.1
Quality19.0
Cash Flow35.1
Moat40.0
Balance Sheet0.0
Debt Purity50.0
Liquid Purity50.0
Rev Purity100.0
Compliance100.0
Tier: WATCH · Score: 38.5 · Rank: #4412
Insider Transactions
No insider transaction data.
Top Institutional Holders
No institutional holder data.
Additional Fundamentals
Enterprise Value
$8.3B
Price/Book
1.25
Beta
1.061
Analysts
5
Total Revenue (TTM)
$2.6B
Total Debt
$1.4B
Rec. Mean
2.80
Short % Float
0.0%
Employees
7,450

Elite Intelligence

Trade Consideration with position sizing, convergence signals, and risk analysis. Available to Elite members.

Upgrade to Elite
Trade Consideration
The Opportunity
Score 43.9 (P56 — top 44.3% of scored tickers). Unknown Moat. Ethical PASS. 5 analysts at Hold.
Price: $305.29 | Target: $297.00 (+-3%)
Score
44
Moat
Unknown
Conviction
Standard
Upside
+-3%
The Fundamentals
Revenue Growth+1.1%
Profit Margin6.5%
ROE2.5%
Forward P/E31.4
Market Cap$8.2B
Position Sizing Scenarios
Stop: $259.50 (-15%) | Entry: $305.29
SharesCostProfit to TargetR:R
To Consensus ($297.00, 5 analysts)
10$3,052.90+$-82.90 (-3%)-0.2R
50$15,264.50+$-414.50 (-3%)-0.2R
100$30,529.00+$-829.00 (-3%)-0.2R
Risk Factors
  • Valuation stretched on forward earnings
The Verdict
Bio-Rad Laboratories, Inc. passes all ethical screens and holds a unknown competitive moat.
Quantitative Grade

A single score combining all analytical layers below. A is strongest, D is weakest.

B
Quant Score
61.4
Risk Grade
LOW_RISK
Layers
7
Risk Profile

How much could this ticker lose on a bad day? These metrics measure worst-case scenarios from historical data.

VaR 95%
-3.8%
worst expected daily loss, 19 in 20 days
CVaR 95%
-5.7%
avg loss on the worst 5% of days
Annual Volatility
Sortino Ratio
0.20
above 1.0 is good
Max Drawdown
-42.1%
Worst Day
Forward Outlook

Based on 10,000 simulated price paths, here is the probability of where this ticker could be in 30, 60, and 90 days.

30d Prob Up
90d Prob Up
Median Return 30d
Liquidity Score
85
Liquidity Grade
HIGHLY LIQUID
Trend & Momentum

What direction is this ticker actually moving, filtered through noise? Is it speeding up or slowing down?

Kalman Trend
Trend Strength
Momentum Signal
HMM Regime
RSI Signal
Technical Signals

Classic chart signals that institutional traders monitor. Golden Cross is bullish, Death Cross is bearish.

MA Crossover
BELOW_200
Bollinger Position
ABOVE_UPPER
Beta
Relative Volume
3.1x
Short Interest
Financial Health

Is this company financially sound? The Z-Score measures bankruptcy risk. The F-Score measures fundamental strength.

Altman Z-Score
below 1.81 = distress zone
Piotroski F-Score
Earnings Beat Rate
Earnings Consistency
Correlations

These tickers tend to move together (positive) or in opposite directions (negative). Useful for portfolio diversification.

Most Correlated
TickerCorrelation
TMO0.608
DHR0.601
RVTY0.601
A0.595
TECH0.586
Inverse Correlated
TickerCorrelation
AYRWF-0.174
SUKOON.AE-0.159
4325.SR-0.152
4326.SR-0.140
SALAM_BAH.AE-0.133
Seasonality

Does this ticker have consistent patterns on certain days or months? Historical tendencies, not guarantees.

Best Day
Tuesday
Worst Day
Thursday
Best Month
Jul
Worst Month
Feb
Fri-Mon Effect
-0.1550964483473483
Momentum Rankings

How does this ticker's recent performance compare to the entire universe? Ranked across 1, 3, 6, and 12-month returns.

1M Return
+13.9%
3M Return
+15.6%
6M Return
-1.3%
12M Return
+38.1%
Momentum Rank
#1205
Momentum Signal
UP

Get our daily market read free. Join thousands of traders.

Free Explorer Access